Case study

02 Feb 2021

Prurigo Nodularis Case Study


Patient Recruitment of an international Phase III study in Prurigo Nodularis successfuly enrolled 6 weeks ahead of schedule.


    • Rare indication
    • Protocol amendment slowed enrollment early in the study
    • Older study population (60-70 years) that struggled with completing eDiaries
    • Request to increase number of patients during study conduct from 200 to 280

    See Other Case Studies

    TFS involved in European global customer’s pre-lau...

    TFS was requested to prepare and conduct a Late Phase global proposal to support the pre-launch activities of two pro...

    Read more

    How TFS Strategic Resourcing Solutions deployed a ...

    Given the catastrophic spread of COVID-19, the search for safe and effective therapies has taken on an unpreced...

    Read more

    TFS & a Global Biotech Company

    As clinical trials grow increasingly complex, timelines shorten, and R&D costs soar. Today’s biopharmaceuti...

    Read more